ARTICLE
|
doi:10.20944/preprints202105.0596.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
Atopic dermatitis; Patient Reported Outcome Measures; Dupilumab; Quality of life; Satisfaction; Efficacy; Safety; Adherence
Online: 25 May 2021 (09:15:21 CEST)